Reproduction, smell, and neurodevelopmental disorders: Genetic defects in different hypogonadotropic hypogonadal syndromes

Frontiers in Endocrinology

Volumn 5, Issue JUL, 2014, Pages

  Valdes Socin, Hernan ^a   Almanza, Matilde Rubio ^a   Fernández Ladreda, Mariana Tomé ^a   Debray, François Guillaume ^a   Bours, Vincent ^a   Beckers, Albert ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Genetics; Hypogonadotropic hypogonadism; Kallman syndrome; Kisspeptin; Male; Olfaction; Reproduction

Indexed keywords

FIBROBLAST GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR 54; GONADORELIN; GONADOTROPIN; LEPTIN RECEPTOR; SEMAPHORIN 3A; TRANSCRIPTION FACTOR HESX1;

ANOSMIA; DEVELOPMENTAL DISORDER; GENE MUTATION; GENETIC DISORDER; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS GONAD SYSTEM; KALLMANN SYNDROME; LOSS OF FUNCTION MUTATION; PHENOTYPE; REPRODUCTION; REVIEW; SMELLING DISORDER;

EID: 84905487657     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00109     Document Type: Review

References (52)

1. Valdes-Socin S, Debray FG, Parent AS, Lebrethon MC, Bourguignon JP, Bours V, et al. How to explore...congenital isolated hypogonadotropic hypogonadism? Rev Med Liege (2010) 65(11):634-41.
2. Semple R, Topaloglu KA. The recent genetics of hypogonadotrophic hypogonadism - novel insights and new questions. Clin Endocrinol (Oxf) (2010) 72(4):427-35. doi: 10.1111/j.1365-2265.2009.03687.x
3. Nachtigall LB, Boepple PA, Pralong FP, Crowley WF Jr. Adult-onset idiopathic hypogonadotropic hypogonadism - a treatable form of male infertility. N Engl J Med (1997) 336:410-5. doi:10.1056/NEJM199702063360604
4. Lippincott MF, True C, Seminara SB. Use of genetic models of idiopathic hypogonadotrophic hypogonadism in mice and men to understand the mechanisms of disease. Exp Physiol (2013) 98:1522-7. doi:10.1113/expphysiol.2013.071910
5. Valdes-Socin H, Salvi R, Thiry A, Daly AF, Pralong FP, Gaillard R, et al. Testicular effects of isolated luteinizing hormone deficiency and reversal by long-term human chorionic gonadotropin treatment. J Clin Endocrinol Metab (2009) 94:3-4. doi:10.1210/jc.2008-1584
6. Trarbach EB, Costa EM, Versiani B, de Castro M, Matias Baptista MT, Mendes Garmes H, et al. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia. J Clin Endocrinol Metab (2006) 91:4006-12. doi:10.1210/jc.2005-2793
7. Pitteloud N, Acierno JS Jr, Meysing A, Eliseenkova AV, Ma J, Ibrahimi OA, et al. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A (2006) 103:6281-6. doi:10.1073/pnas.0600962103
8. Pitteloud N, Hayes FJ, Boepple PA, DeCruz S, Seminara SB, MacLaughlin DT, et al. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab (2002) 87:152-60. doi:10.1210/jcem.87.1.8131
9. Sykiotis GP, Plummer L, Hughes VA, Au M, Durrani S, Nayak-Young S, et al. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci U S A (2010) 107:15140-4. doi:10.1073/pnas.1009622107
10. 3 mutations and clinical manifestation in her heterozygous mother. Horm Res Paediatr (2010) 73:477-81. doi:10.1159/000313373
11. Lewkowitz-Shpuntoff HM, Hughes VA, Plummer L, Au MG, Doty RL, Seminara SB, et al. Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications. J Clin Endocrinol Metab (2012) 97:136-44. doi:10.1210/jc.2011-2041
12. Raivio J, Falardeau A, Dwyer R, Quinton FJ, Hayes VA, Hughes LW, et al. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med (2007) 357:863-73. doi:10.1056/NEJMoa066494
13. Pitteloud N, Acierno JS Jr, Meysing AU, Dwyer AA, Hayes FJ, Crowley WF Jr. Reversible Kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene. J Clin Endocrinol Metab (2005) 90:1317-22. doi:10.1210/jc.2004-1361
14. 3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J Clin Endocrinol Metab (2010) 95:2857-67. doi:10.1210/jc.2009-2320
15. Laitinen EM, Tommiska J, Sane T, Vaaralahti K, Toppari J, Raivio T. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations. PLoS One (2012) 7:e39450. doi:10.1371/journal.pone.0039450
16. Cariboni A, Maggi R. Kallmann's syndrome, a neuronal migration defect. Cell Mol Life Sci (2006) 63(21):2512-26. doi:10.1007/s00018-005-5604-3
17. Bouligand J, Ghervan C, Tello JA, Brailly-Tabard S, Salenave S, Chanson P, et al. Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. N Engl J Med (2009) 360:2742-8. doi:10.1056/NEJMoa0900136
18. Chan YM, de Guillebon A, Lang-Muritano M, Plummer L, Cerrato F, Tsiaras S, et al. GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A (2009) 106:11703-8. doi:10.1073/pnas.0903449106
19. 54. Proc Natl Acad Sci U S A (2003) 100:10972-6. doi:10.1073/pnas.1834399100
20. Topaloglu AK, Tello JA, Kotan LD, Ozbek MN, Yilmaz MB, Erdogan S, et al. Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N Engl J Med (2012) 366:629-35. doi:10.1056/NEJMoa1111184
21. Brioude F, Bouligand J, Francou B, Fagart J, Roussel R, Viengchareun S, et al. Two families with normosmic congenital hypogonadotropic hypogonadism and biallelic mutations in KISS1R (KISS1 receptor): clinical evaluation and molecular characterization of a novel mutation. PLoS One (2013) 8(1):e53896. doi:10.1371/journal.pone.0053896
22. Tenenbaum-Rakover Y, Commenges-Ducos M, Iovane A, Aumas C, Admoni O, de Roux N. Neuroendocrine phenotype analysis in five patients with isolated hypogonadotropic hypogonadism due to a L102P inactivating mutation of GPR54. J Clin Endocrinol Metab (2007) 92:1137-44. doi:10.1210/jc.2006-2147
23. Valdes-Socin H, Cavalier E, Beckaert A, Carlisi A, Chavez M, Beckers A. High plasma kisspeptins in obese men with acquired hypogonadism and in men with congenital hypogonadism: pilot study of plasma kisspeptins variations before and after hCG and testosterone administration. Ann Endocrinol (Paris) (2011).
24. Valdes-Socin H, Munaut C, Chavez M, Chantrain F, Delbecque K, Delvenne P, et al. Expression and spatio-temporal distribution of KISS1 and its receptor KISSR in human normal and pathological placentae. Ann Endocrinol (Paris) (2012) 4:374. doi:10.1016/j.ando.2012.07.494
25. 3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat Genet (2009) 41:354-8. doi:10.1038/ng.306
26. Guran T, Tolhurst G, Bereket A, Rocha N, Porter K, Turan S, et al. A novel missense mutation in the first extracellular loop of the neurokinin B receptor causes hypogonadotropic hypogonadism. J Clin Endocrinol Metab (2009) 94:3633-9. doi:10.1210/jc.2009-0551
27. 3 mutations: characterization of neuroendocrine phenotypes and novel mutations. PLoS One (2011) 6:e25614. doi:10.1371/journal.pone.0025614
28. Farooqi IS, Wangensteen T, Collins S, Kimber W, Matarese G, Keogh JM, et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med (2007) 356:237-47. doi:10.1056/NEJMoa063988
29. Pasqualini RQ, Bur GE. Síndrome hipoandrogénico con gametogénesis conservada: clasificación de la insuficiencia testicular. Rev Asoc Med Argent (1950) 64:15-30.
30. Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley WF, Jameson JL. Hypogonadism caused by a single amino acid substitution in the subunit of luteinizing hormone. N Engl J Med (1992) 326:179-83. doi:10.1056/NEJM199201163260306
31. Valdes-Socin H, Salvi R, Daly AF, Gaillard RC, Quatresooz P, Tebeu P-M, et al. Hypogonadism in a patient with a mutation in the luteinizing hormone-subunit gene. N Engl J Med (2004) 351:2619-25. doi:10.1056/NEJMoa040326
32. Lofrano-Porto A, Barra GB, Giacomini LA, Nascimento PP, Latronico AC, Casulari LA, et al. Luteinizing hormone mutation and hypogonadism in men and women. N Engl J Med (2007) 357:897-904. doi:10.1056/NEJMoa071999
33. Achard C, Courtillot C, Lahuna O, Me'duri G, Soufir JC, Lie're P, et al. Normal spermatogenesis in a man with mutant luteinizing hormone. N Engl J Med (2009) 361:1856-63. doi:10.1056/NEJMoa0805792
34. Basciani S, Watanabe M, Mariani S, Passeri M, Persichetti A, Fiore D, et al. Hypogonadism in a patient with two novel mutations of the luteinizing hormone -subunit gene expressed in a compound heterozygous form. J Clin Endocrinol Metab (2012) 97:3031-8. doi:10.1210/jc.2012-1986
35. Daly A, Valdes-Socin H, Beckers A. A tall man with hypogonadism. In: Wartofsky L, editor. Diagnostic Dilemmas: Images in Endocrinology. Washington DC: The Endocrine Society Press (2011). p. 204-7.
36. Legouis R, Hardelin JP, Levilliers J, Claverie JM, Compain S, Wunderle V, et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell (1991) 67:423-35. doi:10.1016/0092-8674(91)90193-3
37. Sato N, Katsumata N, Kagami M, Hasegawa T, Hori N, Kawakita S, et al. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGR1, or KAL2) in five families and 18 sporadic patients. J Clin Endocrinol Metab (2004) 89:1079-88. doi:10.1210/jc.2003-030476
38. Tsai PS, Gill JC. Mechanisms of disease: insights into X-linked and autosomal-dominant Kallmann syndrome. Nat Clin Pract Endocrinol Metab (2006) 2:160-71. doi:10.1038/ncpendmet0119
39. Dodé C, Levilliers J, Dupont JM, De Paepe A, Le Dû N, Soussi-Yanicostas N, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet (2003) 33:463-5. doi:10.1038/ng1122
40. Dodé C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, Kottler ML, et al. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet (2006) 2(10):e175. doi:10.1371/journal.pgen.0020175
41. Miraoui H, Dwyer AA, Sykiotis GP, Plummer L, Chung W, Feng B, et al. Mutations in FGF17, IL17RD, DUPS6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am J Hum Genet (2013) 92:725-43. doi:10.1016/j.ajhg.2013.04.008
42. Cole LW, Sidis Y, Zhang CK, Quinton R, Plummer L, Pignatelli D, et al. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin releasing hormone deficiency: molecular genetics and clinical spectrum. J Clin Endocrinol Metab (2008) 93:3551-9. doi:10.1210/jc.2007-2654
43. Matsumoto S, Yamazaki C, Masumoto K, Nagano M, Naito M, Soga T, et al. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc Natl Acad Sci U S A (2006) 103:4140-5. doi:10.1073/pnas.0508881103
44. McCabe MJ, Gaston-Massuet C, Gregory LC, Alatzoglou KS, Tziaferi V, Sbai O, et al. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia. J Clin Endocrinol Metab (2013) 98:547-57. doi:10.1210/jc.2012-3067
45. Kramer PR, Wray S. Novel gene expressed in nasal region influences outgrowth of olfactory axons and migration of luteinizing hormone-releasing hormone (LHRH) neurons. Genes Dev (2000) 14:1824-34.
46. Kim HG, Ahn JW, Kurth I, Ullmann R, Kim HT, Kulharya A, et al. WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet (2010) 87(4):465-79. doi:10.1016/j.ajhg.2010.08.018
47. Kim HG, Kurth I, Lan F, Meliciani I, Wenzel W, Eom SH, et al. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet (2008) 83:511-9. doi:10.1016/j.ajhg.2008.09.005
48. Bergman JE, de Ronde W, Jongmans MC, Wolffenbuttel BH, Drop SL, Hermus A, et al. The results of CHD7 analysis in clinically well-characterized patients with Kallmann syndrome. J Clin Endocrinol Metab (2012) 97(5):E858-62. doi:10.1210/jc.2011-2652
49. Tornberg J, Sykiotis GP, Keefe K, Plummer L, Hoang X, Hall JE, et al. Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proc Natl Acad Sci U S A (2011) 108:11524-9. doi:10.1073/pnas.1102284108
50. McNay DE, Turton JP, Kelberman D, Woods KS, Brauner R, Papadimitriou A, et al. HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. J Clin Endocrinol Metab (2007) 92:691-7. doi:10.1210/jc.2006-1609
51. Newbern K, Natrajan N, Kim H-G, Chorich LP, Halvorson LM, Cameron RS, et al. Identification of HESX1 mutations in Kallmann syndrome. Fertil Steril (2013) 99:1831-7. doi:10.1016/j.fertnstert.2013.01.149
52. 3A in human puberty and olfactory system development. Hum Reprod (2012) 27:1460-5. doi:10.1093/humrep/des022